Dr. Montazeri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit Street
Boston, MA 02114Phone+1 617-724-4000- Is this information wrong?
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2017
Iran University of Medical SciencesClass of 2009
Mount Auburn HospitalResidency, Internal Medicine
Certifications & Licensure
MA State Medical License 2014 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma Start of enrollment: 2021 Aug 02
Roles: Contact, Principal Investigator
- IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma Start of enrollment: 2023 Oct 31
Roles: Contact
Publications & Presentations
PubMed
- Detection of Copy-Number Variation in Circulating Cell-Free DNA in Patients With Uveal Melanoma.Takuto Sato, Kamaneh Montazeri, Evangelos S Gragoudas, Anne Marie Lane, Mary Beth Aronow, Justine V Cohen, Genevieve M Boland, Eric Banks, Christopher Kachulis, Mark F...> ;JCO Precision Oncology. 2024 Jan 1
- 4 citationsTebentafusp in the Treatment of Metastatic Uveal Melanoma: Patient Selection and Special Considerations.Kamaneh Montazeri, Vikram Pattanayak, Ryan J Sullivan> ;Drug Design, Development and Therapy. 2023 Jan 1
Hospital Affiliations
Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
